Cell and Gene Therapy

pharma-happenings-for-arrowhead-sartorius-sirnaomics-agc-biologics

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

Arrowhead Halts its ARO-ENaC Phase 1/2 Clinical Trial Arrowhead Pharmaceuticals recently notified about its voluntary decision to put a pause on its ongoing Phase 1/2 clinical study of ARO-ENaC for patients with cystic fibrosis (CF). The announcement came after a preliminary update from an ongoing chronic toxicology study in rats that demonstrated some unexpected signals of local lung inflammation. ARO-ENaC is an investigational RNA interference (RNAi) therapeutic drug, which was undergoing evaluation in a Phase 1/2 clinical trial (AROENaC1001) has now been put on hold with the stoppage on further patient screening, enrollment and dosing while ...

Explore More...

GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; BridgeBio’s R&D deal

recent-pharma-happenings-for-amylyx-orca-lyell-ionis

Amylyx’s neuron-protecting drug slows ALS decline; Antisense drugs could help fight ALS and dementia; CAR-T research updates; Orca and Lyell announces research partnership

pharma-news-updates-for-biomarin-gilead-alzheon

FDA rejects BioMarin’s Valoctocogene Roxaparvovec; J&J inks $6.5B deal; Alzheon bags $47M; Research updates on diabetes

Startup focuses tumors with CAR-T; AbCellera grabs USD 105M; Gilead inks USD 2B deal; GSK’s anti-BCMA antibody receives a boost

CanSino deals with Precision; Atea raises USD 215 M; Applied Molecular Transport targets for USD 100 M IPO; Cell therapy repairs multiple sclerosis in mice

CAR-T cell therapy market for Non-Hodgkin lymphoma

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Cell and Gene Therapy

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; BridgeBio’s R&D deal

Amylyx’s neuron-protecting drug slows ALS decline; Antisense drugs could help fight ALS and dementia; CAR-T research updates; Orca and Lyell announces research partnership

FDA rejects BioMarin’s Valoctocogene Roxaparvovec; J&J inks $6.5B deal; Alzheon bags $47M; Research updates on diabetes

Startup focuses tumors with CAR-T; AbCellera grabs USD 105M; Gilead inks USD 2B deal; GSK’s anti-BCMA antibody receives a boost

CanSino deals with Precision; Atea raises USD 215 M; Applied Molecular Transport targets for USD 100 M IPO; Cell therapy repairs multiple sclerosis in mice

CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities

Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL)

CAR-T in killing tumors; Amunix raises $73M; Autism findings in protein-targeted treatment

More Views & Analysis

Gene therapy might make cocaine less addictive

Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?

In a blind race to cure HIV, can Gene therapy be a deal-breaker?

Autologous cell therapy market: A new paradigm for kidney diseases

Japan is transforming its Healthcare sector through Regenerative Medicine

Zogenix acquires Modis Therapeutics; Amgen buys Otezla; CRISPR slows down the Breast cancer rate

Notizia

Notizia

Subscribe to our Updates

Daily

Weekly

Monthly